ECOPETROL:BVCEcopetrol SA Analysis
Data as of 2026-05-15 - not real-time
COP 2,530.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ecopetrol trades at 2,530 COP, sitting just above its 20‑day SMA (2,488.75) but below the 50‑day SMA (2,555.4), indicating a mixed short‑term bias. The RSI of 51.7 and a bullish MACD histogram (+3.86) suggest modest momentum, while the price remains bounded by a support level around 2,325 COP and resistance near 2,620 COP. Volume has been decreasing and 30‑day volatility is high at 48%, though the beta of –0.27 points to low systematic risk.
Fundamentally, the stock appears undervalued with a trailing P/E of 10.15 versus an industry average of 21.46 and a P/B of 1.24. Dividend yield is attractive at 4.87% with a payout ratio of 43%, but earnings are under pressure – revenue fell 8.7% and profit margin is only 7.5%. The balance sheet is strained: debt‑to‑equity is near 100% and operating cash flow is flat, while Moody’s downgraded the global rating to Ba2 with a negative outlook. Analysts rate the stock as a “hold” and consensus price targets (median 2,200 COP) imply a downside of roughly 9.8%.
Overall, the valuation and dividend appeal are tempered by weak cash generation, high leverage, and deteriorating credit sentiment. Technicals give a slight short‑term upside, but liquidity concerns and credit risk dominate the longer horizon, leading to a hold stance in the near term and a sell recommendation for the longer term.
Fundamentally, the stock appears undervalued with a trailing P/E of 10.15 versus an industry average of 21.46 and a P/B of 1.24. Dividend yield is attractive at 4.87% with a payout ratio of 43%, but earnings are under pressure – revenue fell 8.7% and profit margin is only 7.5%. The balance sheet is strained: debt‑to‑equity is near 100% and operating cash flow is flat, while Moody’s downgraded the global rating to Ba2 with a negative outlook. Analysts rate the stock as a “hold” and consensus price targets (median 2,200 COP) imply a downside of roughly 9.8%.
Overall, the valuation and dividend appeal are tempered by weak cash generation, high leverage, and deteriorating credit sentiment. Technicals give a slight short‑term upside, but liquidity concerns and credit risk dominate the longer horizon, leading to a hold stance in the near term and a sell recommendation for the longer term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram indicating short‑term momentum
- Undervalued valuation metrics (P/E 10.15 vs industry 21.46)
- Decreasing volume and high volatility raising liquidity concerns
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong dividend yield but limited cash flow generation
- High debt‑to‑equity ratio and recent Moody’s downgrade
- Analyst consensus targets below current price suggesting downside
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained earnings contraction and negative revenue growth
- Elevated leverage with minimal operating cash flow
- Credit rating downgrade to Ba2 with a negative outlook
Key Metrics & Analysis
Financial Health
Revenue Growth-8.70%
Profit Margin7.51%
P/E Ratio10.2
Debt/Equity99.96
P/B Ratio1.2
Industry P/E21.5
Technical Analysis
TrendNeutral
RSI51.7
SupportCOP 2,325.00
ResistanceCOP 2,620.00
MA 20COP 2,488.75
MA 50COP 2,555.40
MA 200COP 2,082.75
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Target PriceCOP 2,282.43
Upside/Downside-9.79%
GradeUndervalued
TypeValue
Dividend Yield4.87%
Risk Assessment
Beta-0.27
Volatility48.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.